SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Trillium Therapeutics Inc. – ‘20FR12B/A’ on 11/26/14 – EX-15.1

On:  Wednesday, 11/26/14, at 3:05pm ET   ·   Accession #:  1062993-14-6914   ·   File #:  1-36596

Previous ‘20FR12B’:  ‘20FR12B/A’ on 10/3/14   ·   Latest ‘20FR12B’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/26/14  Trillium Therapeutics Inc.        20FR12B/A              4:1.9M                                   Newsfile Corp/FA

Amendment to Registration of Securities of a Foreign Private Issuer   —   Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20FR12B/A   Amendment to Registration of Securities of a        HTML   1.67M 
                          Foreign Private Issuer                                 
 2: EX-1.8      Underwriting Agreement -- exhibit1-8                HTML     16K 
 3: EX-15.1     Letter re: Unaudited Interim Financial Information  HTML      5K 
                          -- exhibit15-1                                         
 4: EX-15.2     Letter re: Unaudited Interim Financial Information  HTML      5K 
                          -- exhibit15-2                                         


EX-15.1   —   Letter re: Unaudited Interim Financial Information — exhibit15-1


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Trillium Therapeutics Inc.: Exhibit 15.1 - Filed by newsfilecorp.com  

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Statement by Experts” and to the use of our reports dated March 27, 2014 and April 29, 2013 with respect to the financial statements of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) in the Registration Statement on Form 20-F (Amendment No. 2) for the registration of common shares of Trillium Therapeutics Inc.

  /s/ Ernst & Young LLP
Toronto, Canada Chartered Professional Accountants
November 26, 2014 Licensed Public Accountants



Dates Referenced Herein

This ‘20FR12B/A’ Filing    Date    Other Filings
Filed on:11/26/14None on these Dates
3/27/14
4/29/13
 List all Filings 
Top
Filing Submission 0001062993-14-006914   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 1:16:16.1pm ET